Yvonne Engwall
About
In The Last Decade
Yvonne Engwall
9 papers receiving 500 citations
Peers
Comparison fields: 5 of 51
- Pathology and Forensic Medicine 271
- Molecular Biology 165
- Genetics 161
- Oncology 160
- Surgery 115
Countries citing papers authored by Yvonne Engwall
This map shows the geographic impact of Yvonne Engwall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yvonne Engwall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yvonne Engwall more than expected).
Fields of papers citing papers by Yvonne Engwall
This network shows the impact of papers produced by Yvonne Engwall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yvonne Engwall. The network helps show where Yvonne Engwall may publish in the future.
Co-authorship network of co-authors of Yvonne Engwall
This figure shows the co-authorship network connecting the top 25 collaborators of Yvonne Engwall. A scholar is included among the top collaborators of Yvonne Engwall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yvonne Engwall. Yvonne Engwall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Title | Journal | Authors | Indexed citations |
|---|---|---|---|---|
| 1 | Inactivation of promoter 1B of APC causes partial gene silencing: evidence for a significant role of the promoter in regulation and causative of familial adenomatous polyposis | Oncogene | Anna Rohlin, Yvonne Engwall et al. | 44 |
| 2 | Parallel sequencing used in detection of mosaic mutations: Comparison with four diagnostic DNA screening techniques | Human Mutation | Anna Rohlin, Yvonne Engwall et al. | 138 |
| 3 | Clinical characterization and the mutation spectrum in Swedish adenomatous polyposis families | BMC Medicine | Gunilla Kanter-Smoler, Anna Rohlin et al. | 36 |
| 4 | Novel Findings in Swedish Patients With MYH-Associated Polyposis: Mutation Detection and Clinical Characterization | Clinical Gastroenterology and Hepatology | Gunilla Kanter-Smoler, Jan Björk et al. | 22 |
| 5 | A high frequency of germline BRCA1/2 mutations in western Sweden detected with complementary screening techniques | Familial Cancer | Annika Bergman, Yvonne Engwall et al. | 25 |
| 6 | Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: Cumulative risks and APC gene mutations | Gastroenterology | Jan Björk, Lennart Iselius et al. | 174 |
| 7 | Novel mutations in the APC gene and clinical features in Swedish patients with polyposis coli. | PubMed | Margareta Nordling, Yvonne Engwall et al. | 5 |
| 8 | A large deletion disrupts the exon 3 transcription activation domain of the BRCA2 gene in a breast/ovarian cancer family. | PubMed | Margareta Nordling, Per Karlsson et al. | 62 |
| 9 | Novel germline mutations in Swedish von Hippel-Lindau disease patients | International Journal of Oncology | L Wiklund, Margareta Nordling et al. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.